{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:10:29Z","timestamp":1762506629989,"version":"3.40.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T00:00:00Z","timestamp":1443052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T00:00:00Z","timestamp":1443052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s11910-015-0594-5","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T08:10:52Z","timestamp":1443082252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Super-Refractory Status Epilepticus"],"prefix":"10.1007","volume":"15","author":[{"given":"Mauricio Ruiz","family":"Cuero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayiotis N.","family":"Varelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,24]]},"reference":[{"key":"594_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-0404.2007.00803.x","volume":"186","author":"JW Chen","year":"2007","unstructured":"Chen JW, Naylor DE, Wasterlain CG. Advances in the pathophysiology of status epilepticus. Acta Neurol Scand Suppl. 2007;186:7\u201315.","journal-title":"Acta Neurol Scand Suppl"},{"key":"594_CR2","unstructured":"Bourneville DM (1876) L\u2019etat de mal epileptique. In: Recherches cliniques et therapeutiques sur l\u2019epilepsie et l\u2019hysterie. Compte-rendu des observations recueillies a la Salpetriere. Delahaye, Paris"},{"key":"594_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s11910-014-0452-x","volume":"14","author":"S Hocker","year":"2014","unstructured":"Hocker S, Tatum WO, LaRoche S, Freeman WD. Refractory and super-refractory status epilepticus\u2014an update. Curr Neurol Neurosci Rep. 2014;14:452.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"594_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jns.2009.03.023","volume":"284","author":"R Rathakrishnan","year":"2009","unstructured":"Rathakrishnan R, Wilder-Smith EP. New onset refractory status epilepticus (NORSE). J Neurol Sci. 2009;284:220. author reply 20\u20131.","journal-title":"J Neurol Sci"},{"issue":"Suppl 8","key":"594_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1528-1167.2011.03238.x","volume":"52","author":"S Shorvon","year":"2011","unstructured":"Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia. 2011;52 Suppl 8:53\u20136.","journal-title":"Epilepsia"},{"key":"594_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.yebeh.2015.04.054","volume":"47","author":"AM Khawaja","year":"2015","unstructured":"Khawaja AM, DeWolfe JL, Miller DW, Szaflarski JP. New-onset refractory status epilepticus (NORSE)\u2014the potential role for immunotherapy. Epilepsy Behav. 2015;47:17\u201323.","journal-title":"Epilepsy Behav"},{"key":"594_CR7","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1111\/j.1528-1167.2011.03293.x","volume":"52","author":"FY Ismail","year":"2011","unstructured":"Ismail FY, Kossoff EH. AERRPS, DESC, NORSE, FIRES: multi-labeling or distinct epileptic entities? Epilepsia. 2011;52:e185\u20139.","journal-title":"Epilepsia"},{"key":"594_CR8","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/brain\/awr215","volume":"134","author":"S Shorvon","year":"2011","unstructured":"Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802\u201318.","journal-title":"Brain"},{"key":"594_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ane.12336","volume":"132","author":"L Tian","year":"2015","unstructured":"Tian L, Li Y, Xue X, et al. Super-refractory status epilepticus in West China. Acta Neurol Scand. 2015;132:1\u20136.","journal-title":"Acta Neurol Scand"},{"key":"594_CR10","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.eplepsyres.2014.08.010","volume":"108","author":"S Jayalakshmi","year":"2014","unstructured":"Jayalakshmi S, Ruikar D, Vooturi S, et al. Determinants and predictors of outcome in super refractory status epilepticus\u2014a developing country perspective. Epilepsy Res. 2014;108:1609\u201317.","journal-title":"Epilepsy Res"},{"key":"594_CR11","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1001\/archneur.62.9.1428","volume":"62","author":"M Holtkamp","year":"2005","unstructured":"Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord H. A \u201cmalignant\u201d variant of status epilepticus. Arch Neurol. 2005;62:1428\u201331.","journal-title":"Arch Neurol"},{"key":"594_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1212\/WNL.43.3_Part_1.483","volume":"43","author":"DH Lowenstein","year":"1993","unstructured":"Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43:483\u20138.","journal-title":"Neurology"},{"key":"594_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archneur.59.2.205","volume":"59","author":"SA Mayer","year":"2002","unstructured":"Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59:205\u201310.","journal-title":"Arch Neurol"},{"key":"594_CR14","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1001\/archneur.62.11.1698","volume":"62","author":"AO Rossetti","year":"2005","unstructured":"Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62:1698\u2013702.","journal-title":"Arch Neurol"},{"key":"594_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1528-1157.1999.tb02070.x","volume":"40","author":"RJ DeLorenzo","year":"1999","unstructured":"DeLorenzo RJ, Garnett LK, Towne AR, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29\u00a0minutes. Epilepsia. 1999;40:164\u20139.","journal-title":"Epilepsia"},{"key":"594_CR16","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/j.1528-1167.2006.00622.x","volume":"47","author":"S Jenssen","year":"2006","unstructured":"Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia. 2006;47:1499\u2013503.","journal-title":"Epilepsia"},{"key":"594_CR17","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/j.1528-1167.2008.01669.x","volume":"49","author":"FA Lado","year":"2008","unstructured":"Lado FA, Moshe SL. How do seizures stop? Epilepsia. 2008;49:1651\u201364.","journal-title":"Epilepsia"},{"key":"594_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pharmthera.2009.03.012","volume":"123","author":"IL Arancibia-Carcamo","year":"2009","unstructured":"Arancibia-Carcamo IL, Kittler JT. Regulation of GABA(A) receptor membrane trafficking and synaptic localization. Pharmacol Ther. 2009;123:17\u201331.","journal-title":"Pharmacol Ther"},{"key":"594_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.conb.2010.06.001","volume":"20","author":"KR Smith","year":"2010","unstructured":"Smith KR, Kittler JT. The cell biology of synaptic inhibition in health and disease. Curr Opin Neurobiol. 2010;20:550\u20136.","journal-title":"Curr Opin Neurobiol"},{"issue":"Suppl 1","key":"594_CR20","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1111\/j.1528-1157.1999.tb00873.x","volume":"40","author":"RL Macdonald","year":"1999","unstructured":"Macdonald RL, Kapur J. Acute cellular alterations in the hippocampus after status epilepticus. Epilepsia. 1999;40 Suppl 1:S9\u201320. discussion S21-2.","journal-title":"Epilepsia"},{"key":"594_CR21","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1152\/jn.00060.2003","volume":"90","author":"K Lamsa","year":"2003","unstructured":"Lamsa K, Taira T. Use-dependent shift from inhibitory to excitatory GABAA receptor action in SP-O interneurons in the rat hippocampal CA3 area. J Neurophysiol. 2003;90:1983\u201395.","journal-title":"J Neurophysiol"},{"key":"594_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0920-1211(91)90095-W","volume":"10","author":"B Meldrum","year":"1991","unstructured":"Meldrum B. Excitotoxicity and epileptic brain damage. Epilepsy Res. 1991;10:55\u201361.","journal-title":"Epilepsy Res"},{"issue":"Suppl 8","key":"594_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1528-1167.2007.01341.x","volume":"48","author":"H Cock","year":"2007","unstructured":"Cock H. The role of mitochondria in status epilepticus. Epilepsia. 2007;48 Suppl 8:24\u20137.","journal-title":"Epilepsia"},{"key":"594_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0920-1211(01)00334-5","volume":"48","author":"HR Cock","year":"2002","unstructured":"Cock HR, Tong X, Hargreaves IP, et al. Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat. Epilepsy Res. 2002;48:157\u201368.","journal-title":"Epilepsy Res"},{"key":"594_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eplepsyres.2010.07.015","volume":"91","author":"RY Tan","year":"2010","unstructured":"Tan RY, Neligan A, Shorvon SD. The uncommon causes of status epilepticus: a systematic review. Epilepsy Res. 2010;91:111\u201322.","journal-title":"Epilepsy Res"},{"issue":"Suppl 3","key":"594_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1528-1167.2011.03034.x","volume":"52","author":"A Friedman","year":"2011","unstructured":"Friedman A, Dingledine R. Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia. 2011;52 Suppl 3:33\u20139.","journal-title":"Epilepsia"},{"key":"594_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11940-013-0252-7","volume":"15","author":"C Lopinto-Khoury","year":"2013","unstructured":"Lopinto-Khoury C, Sperling MR. Autoimmune status epilepticus. Curr Treat Options Neurol. 2013;15:545\u201356. A well written synopsis of autoimmune SE with a Diagram incorporating diagnosis and treatment.","journal-title":"Curr Treat Options Neurol"},{"key":"594_CR28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1684\/epd.2014.0707","volume":"16","author":"S Ramanathan","year":"2014","unstructured":"Ramanathan S, Wong CH, Rahman Z, Dale RC, Fulcher D, Bleasel AF. Myoclonic status epilepticus as a presentation of caspr2 antibody-associated autoimmune encephalitis. Epileptic Disord. 2014;16:477\u201381.","journal-title":"Epileptic Disord"},{"issue":"Suppl 6","key":"594_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/epi.12276","volume":"54","author":"R Davis","year":"2013","unstructured":"Davis R, Dalmau J. Autoimmunity, seizures, and status epilepticus. Epilepsia. 2013;54 Suppl 6:46\u20139.","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"594_CR30","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1111\/j.1528-1157.1993.tb05905.x","volume":"34","author":"CG Wasterlain","year":"1993","unstructured":"Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia. 1993;34 Suppl 1:S37\u201353.","journal-title":"Epilepsia"},{"key":"594_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12028-013-9840-3","volume":"19","author":"PN Varelas","year":"2013","unstructured":"Varelas PN, Corry J, Rehman M, et al. Management of status epilepticus in neurological versus medical intensive care unit: does it matter? Neurocrit Care. 2013;19:4\u20139.","journal-title":"Neurocrit Care"},{"key":"594_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12028-008-9052-4","volume":"9","author":"PN Varelas","year":"2008","unstructured":"Varelas PN. How I, treat status epilepticus in the Neuro-ICU. Neurocrit Care. 2008;9:153\u20137.","journal-title":"Neurocrit Care"},{"key":"594_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11910-013-0357-0","volume":"13","author":"PN Varelas","year":"2013","unstructured":"Varelas PN, Spanaki MV, Mirski MA. Status epilepticus: an update. Curr Neurol Neurosci Rep. 2013;13:357. A broader recent review of SE, encorporating responsive and refractory status.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"594_CR34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1528-1157.1999.tb00775.x","volume":"40","author":"KB Krishnamurthy","year":"1999","unstructured":"Krishnamurthy KB, Drislane FW. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia. 1999;40:759\u201362.","journal-title":"Epilepsia"},{"key":"594_CR35","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1528-1157.1996.tb00039.x","volume":"37","author":"KB Krishnamurthy","year":"1996","unstructured":"Krishnamurthy KB, Drislane FW. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia. 1996;37:863\u20137.","journal-title":"Epilepsia"},{"key":"594_CR36","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/brain\/aws091","volume":"135","author":"M Ferlisi","year":"2012","unstructured":"Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135:2314\u201328. The most comprehensive review in the topic of SRSE.","journal-title":"Brain"},{"key":"594_CR37","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1186\/cc13883","volume":"18","author":"D Pugin","year":"2014","unstructured":"Pugin D, Foreman B, De Marchis GM, et al. Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. Crit Care. 2014;18:R103.","journal-title":"Crit Care"},{"key":"594_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/088307380201700203","volume":"17","author":"S Singhi","year":"2002","unstructured":"Singhi S, Murthy A, Singhi P, Jayashree M. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol. 2002;17:106\u201310.","journal-title":"J Child Neurol"},{"key":"594_CR39","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s00134-006-0362-8","volume":"32","author":"G Morrison","year":"2006","unstructured":"Morrison G, Gibbons E, Whitehouse WP. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med. 2006;32:2070\u20136.","journal-title":"Intensive Care Med"},{"key":"594_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12028-008-9163-y","volume":"10","author":"H Smith","year":"2009","unstructured":"Smith H, Sinson G, Varelas P. Vasopressors and propofol infusion syndrome in severe head trauma. Neurocrit Care. 2009;10:166\u201372.","journal-title":"Neurocrit Care"},{"key":"594_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0006-8993(98)01080-4","volume":"814","author":"AM Mazarati","year":"1998","unstructured":"Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res. 1998;814:179\u201385.","journal-title":"Brain Res"},{"key":"594_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","volume":"265","author":"AM Mazarati","year":"1999","unstructured":"Mazarati AM, Wasterlain CG. N-methyl-d-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett. 1999;265:187\u201390.","journal-title":"Neurosci Lett"},{"key":"594_CR43","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/epi.12247","volume":"54","author":"N Gaspard","year":"2013","unstructured":"Gaspard N, Foreman B, Judd LM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54:1498\u2013503.","journal-title":"Epilepsia"},{"key":"594_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S1525-5050(02)00643-1","volume":"4","author":"EE Ubogu","year":"2003","unstructured":"Ubogu EE, Sagar SM, Lerner AJ, Maddux BN, Suarez JI, Werz MA. Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav. 2003;4:70\u20135.","journal-title":"Epilepsy Behav"},{"key":"594_CR45","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/00000542-198911000-00005","volume":"71","author":"WA Kofke","year":"1989","unstructured":"Kofke WA, Young RS, Davis P, et al. Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology. 1989;71:653\u20139.","journal-title":"Anesthesiology"},{"key":"594_CR46","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/archneur.61.8.1254","volume":"61","author":"SM Mirsattari","year":"2004","unstructured":"Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004;61:1254\u20139.","journal-title":"Arch Neurol"},{"key":"594_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0749-0704(05)70294-3","volume":"13","author":"TA Payne","year":"1997","unstructured":"Payne TA, Bleck TP. Status epilepticus. Crit Care Clin. 1997;13:17\u201338.","journal-title":"Crit Care Clin"},{"key":"594_CR48","doi-asserted-by":"publisher","first-page":"e113715","DOI":"10.1371\/journal.pone.0113715","volume":"9","author":"TE Gillon","year":"2014","unstructured":"Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee LA. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS One. 2014;9:e113715.","journal-title":"PLoS One"},{"key":"594_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2393-13-34","volume":"13","author":"JM Smith","year":"2013","unstructured":"Smith JM, Lowe RF, Fullerton J, Currie SM, Harris L, Felker-Kantor E. An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management. BMC Pregnancy Childbirth. 2013;13:34.","journal-title":"BMC Pregnancy Childbirth"},{"key":"594_CR50","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/BF01711541","volume":"21","author":"FG Alvarez","year":"1995","unstructured":"Alvarez FG, Guntupalli KK. Isoniazid overdose: four case reports and review of the literature. Intensive Care Med. 1995;21:641\u20134.","journal-title":"Intensive Care Med"},{"key":"594_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12028-008-9092-9","volume":"9","author":"JJ Corry","year":"2008","unstructured":"Corry JJ, Dhar R, Murphy T, Diringer MN. Hypothermia for refractory status epilepticus. Neurocrit Care. 2008;9:189\u201397.","journal-title":"Neurocrit Care"},{"key":"594_CR52","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/epi.12144","volume":"54","author":"GK Motamedi","year":"2013","unstructured":"Motamedi GK, Lesser RP, Vicini S. Therapeutic brain hypothermia, its mechanisms of action, and its prospects as a treatment for epilepsy. Epilepsia. 2013;54:959\u201370.","journal-title":"Epilepsia"},{"issue":"Suppl 8","key":"594_CR53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1528-1167.2011.03240.x","volume":"52","author":"MC Walker","year":"2011","unstructured":"Walker MC. The potential of brain stimulation in status epilepticus. Epilepsia. 2011;52 Suppl 8:61\u20133.","journal-title":"Epilepsia"},{"key":"594_CR54","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.clinph.2005.12.010","volume":"117","author":"LM Schrader","year":"2006","unstructured":"Schrader LM, Stern JM, Wilson CL, et al. Low frequency electrical stimulation through subdural electrodes in a case of refractory status epilepticus. Clinical Neurophysiol. 2006;117:781\u20138.","journal-title":"Clinical Neurophysiol"},{"key":"594_CR55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.surneu.2004.11.026","volume":"64","author":"RV Patwardhan","year":"2005","unstructured":"Patwardhan RV, Dellabadia Jr J, Rashidi M, Grier L, Nanda A. Control of refractory status epilepticus precipitated by anticonvulsant withdrawal using left vagal nerve stimulation: a case report. Surg Neurol. 2005;64:170\u20133.","journal-title":"Surg Neurol"},{"key":"594_CR56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-127-3-199708010-00027","volume":"127","author":"MD Carrasco Gonzalez","year":"1997","unstructured":"Carrasco Gonzalez MD, Palomar M, Rovira R. Electroconvulsive therapy for status epilepticus. Ann Intern Med. 1997;127:247\u20138.","journal-title":"Ann Intern Med"},{"key":"594_CR57","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.yebeh.2012.07.026","volume":"25","author":"M Thordstein","year":"2012","unstructured":"Thordstein M, Constantinescu R. Possibly lifesaving, noninvasive, EEG-guided neuromodulation in anesthesia-refractory partial status epilepticus. Epilepsy Behav. 2012;25:468\u201372.","journal-title":"Epilepsy Behav"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-015-0594-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-015-0594-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-015-0594-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-015-0594-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:03:55Z","timestamp":1744149835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-015-0594-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,24]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["594"],"URL":"https:\/\/doi.org\/10.1007\/s11910-015-0594-5","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"type":"print","value":"1528-4042"},{"type":"electronic","value":"1534-6293"}],"subject":[],"published":{"date-parts":[[2015,9,24]]},"assertion":[{"value":"24 September 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"74"}}